Hybrid approach for percutaneous mitral valve repair (MitraClip®) followed by minimally invasive direct coronary artery bypass (MIDCAB) in a patient with a high risk constellation. - OpacWWW

Tytuł:: Hybrid approach for percutaneous mitral valve repair (MitraClip®) followed by minimally invasive direct coronary artery bypass (MIDCAB) in a patient with a high risk constellation.
Autorzy:: Öner A; Department of Cardiology, Heart Centre Rostock, University of Rostock, Rostock, Germany.
Alozie A; Department of Cardiac Surgery, Heart Centre Rostock, University of Rostock, Rostock, Germany.
Dohmen PM; Department of Cardiac Surgery, Heart Centre Rostock, University of Rostock, Rostock, Germany.; Department of Cardiothoracic Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Źródło:: Journal of cardiac surgery [J Card Surg] 2021 Nov; Vol. 36 (11), pp. 4419-4422. Date of Electronic Publication: 2021 Sep 07.
Typ publikacji:: Case Reports
Język:: English
Imprint Name(s):: Publication: Hoboken, NJ : Wiley-Blackwell
Original Publication: Mount Kisco, N.Y. : Futura Pub. Co., Inc., [c1986-
MeSH Terms:: Cardiac Surgical Procedures*
Coronary Artery Disease*/complications
Coronary Artery Disease*/surgery
Mitral Valve Insufficiency*/surgery
Aged ; Coronary Artery Bypass ; Humans ; Male ; Minimally Invasive Surgical Procedures ; Mitral Valve/diagnostic imaging ; Mitral Valve/surgery ; Treatment Outcome
References:: Ji Q, Qi XM, Shen JQ, et al. Patients over 70 years of age with moderate ischemic mitral regurgitation undergoing surgical revascularization plus mitral valve repair: insights from a single-center study of propensity-matched data. Cardiovasc Diagn Ther. 2019;9:568-577.
Pierard LA, Carabello BA. Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J. 2010;31:2996-3005.
Salmasi MY. Should the mitral valve be repaired for moderate ischemic mitral regurgitation at the time of revascularization surgery? J Card Surg. 2018;33:374-384.
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 2012;33:2451-2496.
Society of Thoracic Surgeons. Adult cardiac surgery database: executive summary: Harvest1. Accessed June 2018. http://www.sts.org/sites/default/files/documents/1stHarvestExecutiveSummary.pdf.
Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23-32.
Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcome of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344-353.
Divchev D, Kische S, Paranskaya L, et al. In-hospital outcome of patients with severe mitral valve regurgitation classified as inoperable and treated with the MitraClip® device. J Interv Cardiol. 2012;25(2):180-189.
Dohmen PM. Benefits of sutureless aortic valves may not be limited to reduced crossclamp time. J Thorac Cardiovasc Surg. 2015;149(1):395-2787.
Hong H, Wu L, Wang Q, Peng YD, Dong NG. Results of a single-stage hybrid procedure for patients with coronary and mitral valve disease. Int J Cardiol. 2016;209:328-329.
D'ascenzo F, Moretti C, Marra WG, et al. Meta-analysis of the usefulness of Mitraclip in patients with functional mitral regurgitation. Am J Cardiol. 2015;116(2):325-331.
Boylan MJ, Lytle BW, Loop FD, et al. Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up. J Thorac Cardiovasc Surg. 1994;107(3):657-662.
Contributed Indexing:: Keywords: MIDCAB; MitraClip®; coronary artery disease; mitral valve regurgitation
Entry Date(s):: Date Created: 20210907 Date Completed: 20211004 Latest Revision: 20211004
Update Code:: 20240105
DOI:: 10.1111/jocs.15967
PMID:: 34490951
: Raport

Pełny tekst

Background: We present a 76-year-old poly-morbid male patient suffering from severe ischemic mitral valve regurgitation. A hybrid approach was suggested by the heart team to treat his multifaceted cardiac pathologies.
Methods: At first percutaneous mitral valve repair with the mitraclip device was performed to reduce surgical risk. This was then followed by minimally invasive direct coronary artery bypass (MIDCAB).
Results: At day 20 Post mitraclip intervention the patient suffered gastrointestinal bleeding which needed argon plasma coagulation (APC)-therapy and multiple blood transfusions. Stage II of the hybrid procedure was executed on post-intervention day 34 by minimally invasive direct coronary artery bypass (MIDCAB) to left anterior descending artery (LAD). Seven days later the patient was discharged. Up to two years of follow-up, the patient is in stable condition, without recurrent cardiac symptoms.
Conclusion: Hybrid approach of percutaneous mitral valve repair followed by MIDCAB is an effective minimally invasive treatment for severe ischemic mitral valve regurgitation and coronary artery disease.
(© 2021 Wiley Periodicals LLC.)

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja

Hybrid approach for percutaneous mitral valve repair (MitraClip®) followed by minimally invasive direct coronary artery bypass (MIDCAB) in a patient with a high risk constellation.